<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02977234</url>
  </required_header>
  <id_info>
    <org_study_id>ASU123</org_study_id>
    <nct_id>NCT02977234</nct_id>
  </id_info>
  <brief_title>Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx</brief_title>
  <official_title>Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate in Patients With Hydrosalpinx</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effectiveness of hysteroscopic tubal application
      of Iso Amyl-2-cyanoacrylate in occluding uterine tubes of infertile women with hydrosalpinx,
      which would make it an easy approach for occluding tubes with hydrosalpinx prior to IVF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be conducted according to the guidelines on human experimentation of the 1975
      Declaration of Helsinki. For all patients after taking signed informed consent ,
      transcervical hysteroscopic cannulation of the proximal one centimeter of fallopian tubes
      with hydrosalpinx, will be done using a 4 Fr, 42cm long, polyethylene ureteric catheter,
      where 0.5 ml of Iso Amyl-2-cyanoacrylate (AMCRYLATEÂ®) will be injected.

      All the surgical procedures will be performed without anesthesia, only premedication with an
      NSAID (e.g. NaproxenR) is given orally one hour before the procedure.

      Each patient will be under close observation for the first 24 hours postprocedure for any
      signs of inflammation as abdominal pain, tenderness or fever and for the vital data.

      Hysterosalpingography will be done for all patients 0ne and 3 months postinjection to confirm
      tubal occlusion prior to IVF.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fallopian tubal occlusion in patients with hydrosalpinx.</measure>
    <time_frame>from one to three months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hydrosalpinx</condition>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>Iso-Amyl 2-Cyano Acrylate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoamyl 2-Cyanoacrylate</intervention_name>
    <arm_group_label>Iso-Amyl 2-Cyano Acrylate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Infertile women due to tubal factor with hydrosalpinx (unilateral or bilateral) prepared
        for IVF.

        Exclusion Criteria:

          1. Acute Pelvic inflammatory disease.

          2. Intra uterine pathology
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed I Amer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University maternity hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed I Amer, MD</last_name>
    <phone>oo2o1oo1519370</phone>
    <email>mohamed_amer810@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AIn Shams University Maternity Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11357</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Amer, MD</last_name>
      <phone>00201001519370</phone>
      <email>mohamed_amer810@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2016</study_first_submitted>
  <study_first_submitted_qc>November 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2016</study_first_posted>
  <last_update_submitted>December 25, 2017</last_update_submitted>
  <last_update_submitted_qc>December 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mohamed I Amer</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

